Current trends in cell therapy for pediatric acquired brain injury

Minerva Pediatrica

Volumn 62, Issue 1, 2010, Pages 91-106

  Walker, P A ^a   Harting, M T ^a   Shah, S K ^a   Cox Jr , C S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Brain injuries; Child; Stem cells

Indexed keywords

HYPERTONIC SOLUTION; MOLECULAR SCAFFOLD; MYELIN BASIC PROTEIN; NEUROTROPHIC FACTOR; TOLL LIKE RECEPTOR;

ACCELERATION; BRAIN EDEMA; BRAIN FUNCTION; BRAIN PERFUSION; CELL DEATH; CELL HOMING; CELL THERAPY; CELL VIABILITY; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DECELERATION; DISEASE COURSE; EMERGENCY CARE; ENGRAFTMENT; EXCITOTOXICITY; GENE TRANSFER; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; HYDROGEL; HYPOXIA; IN VITRO STUDY; IN VIVO CULTURE; INDUCED HYPOTHERMIA; INFLAMMATION; INTRACRANIAL PRESSURE; INTRAVENOUS ADMINISTRATION; MORTALITY; NERVE CELL LESION; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PEDIATRICS; PROTEIN SECRETION; REVIEW; STEM CELL; THERAPY EFFECT; TRANSLATION REGULATION; TRAUMATIC BRAIN INJURY; UNITED STATES;

BRAIN INJURIES; CELL TRANSPLANTATION; CHILD; HUMANS;

EID: 77952767392     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Langlois JA, Rudand-Brown W, Thomas KE. The incidence of traumatic brain injury among children in the United States: differences by race. J Head Trauma Rehabil 2005;20:229-238
2. Hawley CA, Ward AB, Magnay AR, Long J. Outcomes following childhood head injury: a population study. J Neurol Neurosurg Psychiatry 2004;75:737-742 (Pubitemid 38526686)
3. Gray DS, Burnham RS. Preliminary outcome analysis of a long-term rehabilitation program for severe acquired brain injury. Arch Phys Med Rehabil 2000;81:1447-1456
4. Cowen TD, Meythaler JM, DeVivo MJ, Ivie CS 3rd, Lebow J, Novack TA. Influence of early variables in traumatic brain injury on functional independence measure scores and rehabilitation length of stay and charges. Arch Phys Med Rehabil 1995;76:797-803.
5. Walker P, Harting MT, Baumgartner JE, Fletcher S, Strobel N, Cox CS Jr. Modern approaches to pediatric brain injury therapy. J Trauma 2009 [In press].
6. NIH.gov. Combination therapies for traumatic brain injury workshop. [cited 2009 October 30]. Available at: http://www.ninds.nih.gov/news-and-events/ proceedings/Combination-Therapies-for-Traumatic-Brain-Injury-Workshop.htm
7. Moppett IK. Traumatic brain injury: assessment, resuscitation and early management. Br J Anaesth 2007;99:18-31. (Pubitemid 47082215)
8. Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS Jr. Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy. Surgery 2008;144:803-813
9. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 2008;25:719-738 (Pubitemid 351957931)
10. Cernak I. Animal models of head trauma. NeuroRx 2005;2:410-422
11. Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 2007;24:1793-1801
12. Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM. Serum neuron-specific enolase, S100B1 and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J Neurosurg 2005;103:61-68 (Pubitemid 44954950)
13. Noppens R, Brambrink AM. Traumatic brain injury in children - clinical implications. Exp Toxicol Pathol 2004;56:113-125 (Pubitemid 39486853)
14. Bullock R, Zauner A, Myseros JS, Marmarou A, Woodward JJ, Young HF. Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann N Y Acad Sci 1995;765:290-7; discussion 8.
15. Yi JH, Hazell AS. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int 2006;48:394-403. (Pubitemid 43327279)
16. Casey PA, McKenna MC, Fiskum G, Saraswati M, Robertson CL. Early and sustained alterations in cerebral metabolism after traumatic brain injury in immature rats. J Neurotrauma 2008;25:603-614 (Pubitemid 351918441)
17. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA et al. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg 1997;86:241-251 (Pubitemid 27130684)
18. Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience 2004;129:1021-1029
19. 19- Buki A, Siman R, Trojanowski JQ, Povlishock JT. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol 1999;58:365-375 (Pubitemid 29187899)
20. Marmarou A, Fatouros PP, Barzo P, Portella G, Yoshihara M, Tsuji O et al. Contribution of edema and cerebral blood volume to traumatic brain swelling in head-injured patients. J Neurosurg 2000;93:183-193 (Pubitemid 30604858)
21. Dietrich WD, Alonso O, Halley M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma 1994;11:289-301. (Pubitemid 24282554)
22. Bouma GJ, Muizelaar JP, Stringer WA, Choi SC, Fatouros P, Young HF. Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J Neurosurg 1992;77:360-368
23. Oertel M, Boscardin WJ, Obrist WD, Glenn TC, McArthur DL, Gravori T et al. Posttraumatic vasospasm: the epidemiology, severity, and time course of an underestimated phenomenon: a prospective study performed in 299 patients. J Neurosurg 2005;103: 812-824 (Pubitemid 43194574)
24. Chen G, Shi J, Hu Z, Hang C. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine. Mediators Inflamm 2008;2008:716458. (Pubitemid 352000408)
25. Bell MJ, Kochanek PM, Doughty LA, Carcillo JA, Adelson PD, Clark RS et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma 1997;14: 451-457
26. Whalen MJ, Carlos TM, Kochanek PM, Wisniewski SR, Bell MJ, Clark RS et al. Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med 2000;28:929-934 (Pubitemid 30262057)
27. Singhal A, Baker AJ, Hare GM, Reinders FX, Schlichter LC, Moulton RJ. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma 2002;19:929-937
28. Lloyd E, Somera-Molina K, Van Eldik LJ, Watterson DM, Wainwright MS. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflammation 2008;5:28.
29. Xiong Y, Peterson PL, Lee CP. Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats. J Neurotrauma 1999;16:1067-1082
30. Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernández J et al. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol 2003;181:130-148 (Pubitemid 36629235)
31. Penkowa M, Moos T, Carrasco J, , Hadberg H, Molinero A, Bluethmann H et al. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 1999;25:343-357 (Pubitemid 29083834)
32. Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab 2006;26: 1407-1418
33. Singh IN, Sullivan PG, Hall ED. Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J Neurosci Res 2007;85:2216-2223
34. Weiner LP. Definitions and criteria for stem cells. Methods Mol Biol 2008;438:3-8.
35. Scadden DT. The stem-cell niche as an entity of action. Nature 2006;441:1075-1079
36. Kim JM, Lee ST, Chu K, Jung KH, Song EC, Kim SJ et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007;1183:43-50.
37. Gao J, Prough DS, McAdoo DJ, Grady JJ, Parsley MO, Ma L et al. Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. Exp Neurol 2006;201: 281-292 (Pubitemid 44344239)
38. Mahmood A, Lu D, Wang L, Li Y, Lu M, Chopp M. Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 2001;49:1196-203; discussion 203-204 (Pubitemid 32285175)
39. Lu D, Sanberg PR, Mahmood A, Li Y, Wang L, Sanchez-Ramos J et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 2002;11: 275-281
40. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084 (Pubitemid 44128350)
41. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74 (Pubitemid 27161245)
42. Lu D, Mahmood A, Wang L, Li Y, Lu M, Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001;12:559-563 (Pubitemid 32173965)
43. 43- Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002;297:1299. (Pubitemid 34913161)
44. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Litde evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297:2256-2259
45. Roybon L, Ma Z, Asztely F, Fosum A, Jacobsen SE, Brundin P et al. Failure of transdifferentiation of adult hematopoietic stem cells into neurons. Stem Cells 2006;24:1594-1604 (Pubitemid 44464677)
46. Newman MB, Willing AE, Manresa JJ, Davis-Sanberg C, Sanberg PR. Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev 2005;14:576-586 (Pubitemid 41780809)
47. Jiang L, Newman M, Saporta S, Chen N, Sanberg C, Sanberg PR et al. MIP-lalpha and MCP-1 Induce Migration of Human Umbilical Cord Blood Cells in Models of Stroke. Curr Neurovasc Res 2008;5:118-124 (Pubitemid 351838577)
48. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822 (Pubitemid 40223708)
49. Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 2008;251:131-136
50. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, Sanberg PR et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 2006;199:191-200. (Pubitemid 43949266)
51. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD et al. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 2005;14:595-604. (Pubitemid 41780811)
52. Penkowa M, Giralt M, Carrasco J, Hadberg H, Hidalgo J. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 2000;32: 271-285
53. Qu R, Li Y, Gao Q, Shen L, Zhang J, Liu Z et al. Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts. Neuropathology 2007;27: 355-363 (Pubitemid 47063283)
54. Chen X, Katakowski M, Li Y, Lu D, Wang L, Zhang L et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 2002;69:687-691 (Pubitemid 34966882)
55. Zhou C, Zhang C, Chi S, Xu Y, Teng J, Wang H et al. Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Brain Res 2009; 1269:23-30.
56. Mahmood A, Lu D, Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 2004;21:33-39 (Pubitemid 38141800)
57. Lu D, Li Y, Wang L, Chen J, Mahmood A, Chopp M. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma 2001;18:813-819 (Pubitemid 32769777)
58. Chen Q, Long Y, Yuan X, Zou L, Sun J, Chen S et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 2005;80:611-619 (Pubitemid 40896182)
59. 59- Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003;92:692-699 (Pubitemid 36417705)
60. Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 2009;216:47-55.
61. Chen J, Li Y, Zhang R, Katakowski M, Gautam SC, Xu Y et al. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res 2004;1005:21-28 (Pubitemid 38388396)
62. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Nad Acad Sci U S A 2003;100:2397-2402 (Pubitemid 36297510)
63. Rothenaigner I, Kramer S, Meggendorfer M, Rethwilm A, Brack-Werner R. Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression. Gene Ther 2009;16:349-358
64. Dieterlen MT, Wegner F, Schwarz SC, Milosevic J, Schneider B, Busch M et al. Non-viral gene transfer by nucleofection allows stable gene expression in human neural progenitor cells. J Neurosci Methods 2009;178:15-23.
65. Leng S, He J, Fan W, Cheng S, Long D, He H. Bone mesenchymal stem cells for gene transfer of NGF to the adult rat brain: rescue the NGFR p75 positive neurons from fimbria-fornix lesion-induced degeneration. Neurosci Lett 2008;448:282-287
66. Leng SL, Fan WG, Qu HG, Xu SC, Zhong WY, Zhang WY et al. Transplantation of bone mesenchymal stem cells containing the nerve growth factor gene in adult rat brain with Fimbria Fornix lesion. Brain Res 2009.
67. Makar TK, Trisler D, Bever CT, Goolsby JE, Sura KT, Balasubramanian S et al. Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis. J Neuroimmunol 2008;196:67-81.
68. Uzzaman M, Keller G, Germano IM. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas. Neuro Oncol 2009;11:102-108
69. Allere C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004;78:503-508 (Pubitemid 39097094)
70. Boomsma RA, Swaminathan PD, Geenen DL. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int J Cardiol 2007;122:17-28.
71. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999-3001. (Pubitemid 36857986)
72. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001;32:2682-2688
73. Zawadzka M, Lukasiuk K, Machaj EK, Pojda Z, Kaminska B. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiol Exp (Wars) 2009;69:46-51.
74. H Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 2009.
75. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009;18:683-692
76. Harting MT, Jimenez F, Cox CS Jr. The pulmonary first-pass effect, xenotransplantation and translation to clinical trials - a commentary. Brain 2008;131:e100; author reply e1.
77. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc 2007;39:573-576 (Pubitemid 46386222)
78. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2008.
79. 79- Shen LH, Li Y, Chen J, Zhang J, Vanguri P, Borneman J et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 2006;137:393-399 (Pubitemid 43031506)
80. Guzman R, De Los Angeles A, Cheshier S, Choi R, Hoang S, Liauw J et al. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 2008;39:1300-1306 (Pubitemid 351440705)
81. Lappalainen RS, Narkilahti S, Huhtala T, Liimatainen T, Suuronen T, Närvänen A et al. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci Lett 2008;440:246-250
82. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz- Cabello J, Young RG et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008;39:1569-1574
83. Mahmood A, Lu D, Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 2004;55:1185-1193 (Pubitemid 39525223)
84. Mahmood A, Lu D, Wang L, Chopp M. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma 2002;19:1609-1617 (Pubitemid 36026216)
85. Liao W, Xie J, Zhong J, Liu Y, Du L, Zhou B et al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009;87:350-359
86. Harting MT, Sloan LE, Jimenez F, Baumgartner J, Cox CS Jr. Subacute neural stem cell therapy for traumatic brain injury. J Surg Res 2009;153:188-194
87. Riess P, Zhang C, Saatman KE, Laurer HL, Longhi LG, Raghupathi R et al. Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 2002;51:1043-52; discussion 52-54 (Pubitemid 36331043)
88. Philips MF, Mattiasson G, Wieloch T, Björklund A, Johansson BB, Tomasevic G et al. Neuroprotective and behavioral efficacy of nerve growth factor-transfected hippocampal progenitor cell transplants after experimental traumatic brain injury. J Neurosurg 2001;94:765-774
89. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC et al. Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035-3039 (Pubitemid 40524580)
90. Choumerianou DM, Dimitriou H, Perdikogianni C, Martimianaki G, Riminucci M, Kalmanti M. Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow. Cell Prolif 2008;41:909-922
91. Bernardo ME, Zaffaroni N, Nóvara F, Cometa AM, Avanzini MA, Moretta A et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67:9142-9149-
92. Fan L, Du F, Cheng BC, Peng H, Liu SQ. Migration and distribution of bone marrow stromal cells in injured spinal cord with different transplantation techniques. Chin J Traumatol 2008;11:94-97 (Pubitemid 351559916)
93. Ohta M, Suzuki Y, Noda T, Ejiri Y, Dezawa M, Kataoka K et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004;187:266-278
94. Liu W, Jiang X, Fu X, Cui S, Du M, Cai Y et al. Bone marrow stromal cells can be delivered to the site of traumatic brain injury via intrathecal transplantation in rabbits. Neurosci Lett 2008;434:160-164
95. Guillot PV, Cui W, Fisk NM, Polak DJ. Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med 2007;11:935-944
96. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926
97. Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 2002;295:1009-1014
98. Sands RW, Mooney DJ. Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol 2007;18:448-453 (Pubitemid 350116593)
99. Liao S, Li B, Ma Z, Wei H, Chan C, Ramakrishna S. Biomimetic electrospun nanofibers for tissue regeneration. Biomed Mater 2006;1:R45-53. (Pubitemid 44529331)
100. Purcell EK, Singh A, Kipke DR. Alginate composition effects on a neural stem cell-seeded scaffold. Tissue Eng Part C Methods 2009 [Epub ahead of print].
101. Bible E, Chau DY, Alexander MR, Price J, Shakesheff KM, Modo M. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials 2009;30:2985-2994
102. Purcell EK, Seymour JP, Yandamuri S, Kipke DR. In vivo evaluation of a neural stem cell-seeded prosthesis. J Neural Eng 2009;6:026005.
103. Willerth SM, Sakiyama-Elbert SE. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev 2007;59:325-338 (Pubitemid 46879972)
104. Jen AC, Wake MC, Mikos AG. Review: hydrogels for cell immobilization. Biotechnol Bioeng 1996;50:357-364
105. Nisbet DR, Crompton KE, Home MK, Finkelstein DI, Forsythe JS. Neural tissue engineering of the CNS using hydrogels. J Biomed Mater Res B Appl Biomater 2008;87:251-263
106. Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008;68:34-45.
107. Kopecek J. Hydrogel biomaterials: a smart future? Biomaterials 2007;28:5185-5192
108. Nisbet DR, Moses D, Gengenbach TR, Forsythe JS, Finkelstein DI, Home MK. Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury. J Biomed Mater Res A 2008.
109. Zhao J, Zhang N, Prestwich GD, Wen X. Recruitment of endogenous stem cells for tissue repair. Macromol Biosci 2008;8:836-842
110. Jongpaiboonkit L, King WJ, Murphy WL. Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng Part A 2009;15:343-353
111. Isakova IA, Baker K, DuTreil M, Dufour J, Gaupp D, Phinney DG. Age- and dose-related effects on MSC engraftment levels and anatomical distribution in the central nervous systems of nonhuman primates: identification of novel MSC subpopulations that respond to guidance cues in brain. Stem Cells 2007;25:3261-3270
112. Potapova IA, Brink PR, Cohen IS, Doronin SV. Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem 2008;283:13100-13107
113. Shi M, Li J, Liao L, Chen B, Li B, Chen L et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007;92:897-904. (Pubitemid 350144236)
114. Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M. Ex vivo delivered stromal cell-derived factor-lalpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 2007;42:792-803. (Pubitemid 46527603)
115. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2007;2:e416.
116. Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 2008;26: 99-107.